We would love to hear your thoughts about our site and services, please take our survey here.
smart bot system. Between 13.11 and 13.16, since there were not many buys few tiny sells (even 4 5 shares) alog trades brought sp down by about 1p. But buys are much more volume and bigger value but that doesn't increase price in equal proportion. Just observation, though I am cool and very confident little wait of few weeks and this can give great rewards.
Interesting, thanks for sharing.
Lots of buys coming this morning.
Hi Sang1, you sometimes put interesting posts, but why repeating aim delisting point. 4D won't delist on aim in 2021 after just listing on Nasdaq, that kind of scenario will arise at least couple of years later. You yourself said Verona delisted on aim after 5 years of nasdaq listing, so raise this in 2023-24. By that time if ISA account is headache for ADR, people will sell from ISA and buy into non-ISA. I have accounts in IG (non-ISA) and Barclays (ISA) and most of my 4D shares are in Barclays but I may after year move some shares from Barclays into ISA. You always get chance to sell and buy without any loss (just commission of 5-10£) between 2 accounts. So you are unnecessarily being worried. If it is for tax matter, even then at least first couple of years profit you can keep in ISA and when such scenario arise, you can move.
He is steadfast in spreading negativity here. Cannot tolerate anybody putting slightly higher target, putting irrelevant and senseless points. For past few days he was scaring investors 4D will delist from AIM, so sell off from ISA account etc. giving example of Verona and today he/she him/herself said Verona listed 5 years back on Nasdaq. Steven, March lows and all senseless points he/she is putting like Voleon representative.
Look at consistent auto trades of small sell quantities. You won't see such trades in most other stocks. Same pattern on MTRO where voleon has short position. I wish voleon get burnt like in novacyt they did (https://twitter.com/bill_ohreally/status/1314189611665690625?s=20) . we need some solid announcement from 4D to get voleon out from here.
Currently voleon has short position in 4D and Metro bank (MTRO). On both there are so many algo trades (small sells of tiny amounts) unlike other shares. Voleon did short ncyt like dddd from July to Oct. https://twitter.com/bill_ohreally/status/1314189611665690625?s=20
They kept ncyt share price suppressed for 1-2 months, though couldn't drag it down too much but then they had to close short positions with loss and while they were closing sp shoot to double and kept rising after they close their position. So on 4D, those shareholders who can keep patience and not panic will be ultimate winner with handsome profit. There should be also some regulation on such small algo trades manipulating sp.
https://app.researchpool.com/provider/bryan-garnier/4d-pharma-dddd-4d-pharma-presentations-at-sitc-2020-highlight-the-proposed-moa-of-mrx-4CIbNZecex?utm_source=dlvr.it&utm_medium=twitter
The report is not available free. Even request price button is blocked for some reports and available for some reports from Bryan Garnier. I guess it is available only to BG clients or has to be bought and I guess must be high price to access it.
Very bad maths. But regardless what are you trying to suggest?
in rns company clearly said will continue listing on AIM. 4D also had tweeted same in reply to investor: https://twitter.com/4dpharmaplc/status/1321790783503142919?s=20
So, I don't think company will stop listing in UK, may rather move to ftse from aim when valuation grows.
I believe because, once listed on nasdaq, US investors will pounce on to buy as company way undervalued compared to its potential. And nasdaq and aim price cannot be out of sync, so AIM price will also increase and shorters have to close position. Before nasdaq we should get full data release for IBS phase 2 trial. Hoping with that they might get some partner on board for IBS and then also something from Merch (either for mx518 or vaccine upfront payment).
Exactly, in hindsight if 4D had rns out on pfizer news day in morning it could have got share price gained good % and found higher support (not chartist but from past observation found £1.26 as good support). It was worst time for rns as was just within an hour after pfizer news when many small cap (mainly covid test & treatment) stocks sp tanked. I don't blame company as they were right to publish in afternoon just before publishing posters at SITC and nobody would have predicted such turn of events. Now for 4D to get momentum needs some more positive news (partnership or Duncan interview with some solid news etc.). I am not worried about 4D share price, as it cannot go much down. It has solid support at 0.93 and when it goes up it should be quick pace. Voleon would be happy seeing impatient shareholders selling and giving them profit.
This stock price is manipulated by algo trades. I am seeing few auto trade (buy) for last 2 days so that might be shorts getting reduced. That is good news as then sp will be allowed to rise as it should be. I am sure, one day it will have explosive move upwards and share optimism by other contributors here, this stock has too much potential and can go very high. Market is trying typically to frustrate holders so they sell shares and then will have sudden rise catching all such SH out. What is not to like in this share (so much in pipeline, very undervalued, great recent readouts, collaboration with big companies, leader in field with not much competition, management holding large % of shares, soon to be listed on Nasdaq). Merck just announced stopping joint trial with Ketruda (https://endpts.com/merck-pulls-the-plug-on-a-study-evaluating-blockbuster-keytruda-with-yervoy-for-nsclc/) with another company today due to side effects. 4D has 100% safety as using natural gut bacteria unlike other medicines and with efficacy data also impressive, it should get faster approval and Merck will also be very much interested.
One thing to learn from today's market is when price moves, it will be explosive. Who would have thought shares like easyjet, IAG, cineworld, cinemark and others would increase 30-50 % in a day. Lots of trader would have been caught out without getting chance to earn. So DDDD, PI s may sell thinking will get in back once it stabilize, but market won't give chance when it goes to price it is worthy of. It will increase 40-50 % straightaway without giving any chance to get back in this share.
4D stock should not have been affected by Pfizer vaccine news. I believe 4D stock price got down only because some PI got panicked seeing ncyt, sng, avtc etc. being down too much. But those shares market cap are too high and all are solely relying on covid for their growth at this stage. 4D is completely different and its main pipeline is all around cancer, IBS, asthma etc. Today's rns was fantastic and could have easily got SP higher by around 20% if there was no panic selling in small cap covid stocks today which dragged other small caps as well. I am quite sure this will bounce back soon (now with monotherapy and part B data released). It needs to go above £1.26 then it will have explosive move.
presentations are on 11th, 12th and 14th Nov. So probably rns can come anytime up to 11th morning. https://sitc.sitcancer.org/2020/abstracts/titles/index.php?filter=mrx
posters are on display from today 8 am (US eastern time).
Again for last 2 days, despite buy volume much higher than sell (more than 30%), sp is brought down and allowed to grow only 2-3%. If it was other way around (sell volume more than by by 30%), based on past few days, price would have been dragged down more than 5%. Looks like MMs giving full support to Citadel, Voleon not to burn them on shots. Hopefully they will close shorts today afternoon and allow SP to rise at EOD and next week we will surely have blockbuster data on monotherapy and part B of combined trial with Ketruda.
Thanks Phil. I think we should have monotherapy and ketuda combo trial data released by next week as to be presented at SITC, which should be positive based on director's confidence. That should certainly increase share price. Current share price is mainly pulled down by shorting after 7th Oct. I was of view shorters would reduce their shorting this week before SITC conference. Though regardless I think best approach with this share is to be patient. As when it will rise it will rise exponentially. The way some UK pharma companies (e.g. #hzd, #LID) bought today by US companies at premium. One more dutch company Kiadis Pharma (KDIS) is bought by Sanofi 3 times of price. There are bright prospects for 4D with its unique position and so much in pipeline.
Have been following sp and buy/sell volumes for few days. Whenever buy volume is higher , sp is increased mildly (if margin is like 200K more shares), flat (if margin is less than 200k) and increased at the end of day (if diff of buy over sell is very high). But if sell is higher than buy then price is reduced by much more even for lesser difference (selling not too much more than buying). To me seems MMs colluding with shorters and controlling price at will. There must be investigation and strict rules&guidelines for controlling any corruption.
Have been following share price of 4D and its buy/sell volumes. I don't know much in detail how sp is set but whenever buy is much higher than sell, sp is set bit higher or even flat sometime and when sell is even slightly higher than buy, sp is reduced much more. Not sure if market manipulators in collusion with shorters are deliberately keeping SP down? There should be investigation and strict rules/guidelines so that AIM sp is not corruptly manipulated.